Trials / Completed
CompletedNCT05330312
Controlled Investigation to Evaluate Impact of dCBT on Psychological Symptom Burden in Adult Subjects With PF
A Randomized, Controlled, Parallel-group Clinical Investigation Evaluating the Impact of Digital Cognitive Behavioural Therapy on Psychological Symptom Burden in Adults Diagnosed With Pulmonary Fibrosis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 119 (actual)
- Sponsor
- Vicore Pharma AB · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to assess efficacy and safety of a digital cognitive behavioural therapy for patients with pulmonary fibrosis on anxiety.
Detailed description
Patients will be randomised 1:1 to either receive treatment with the digital therapy, or to act as control group. Patients will be treated for 9 weeks, followed by a 3 week follow-up period. Efficacy will be assessed after 9 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Digital cognitive behavioral therapy | Therapy for patients with pulmonary fibrosis |
Timeline
- Start date
- 2022-04-17
- Primary completion
- 2023-10-19
- Completion
- 2023-11-10
- First posted
- 2022-04-15
- Last updated
- 2024-09-24
- Results posted
- 2024-09-24
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05330312. Inclusion in this directory is not an endorsement.